Illumina · 3 days ago
Director, Arrays R&D
Illumina is expanding access to genomic technology to realize health equity for billions of people around the world. They are seeking a dynamic and experienced R&D Leader to provide strategic insights and leadership for the Arrays business unit, collaborating with cross-functional teams and driving continuous improvement in R&D operations.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Work closely with the other members of the Arrays Leadership Team to develop and support a vision for the Arrays business, balancing short-term gains with long-term strategic value
Collaborate with R&D, Global Operations, and Commercial leadership to ensure tactical and strategic goals of the Arrays BU are understood and supported
Define and implement the operational strategy for the Arrays R&D function aligned with the BU’s and company's overall objectives
Develop and communicate clear goals and performance metrics to measure and track the effectiveness of Arrays R&D operations
Analyze current Arrays R&D processes and identify areas for improvement to optimize time-to-market, robustness, efficiency, and resource utilization
Scrutinize R&D resource estimates, timelines, and scope associated with Arrays projects
Drive continuous improvement initiatives to enhance productivity, streamline workflows, and promote innovation within the Arrays R&D group
Work closely with Finance to manage within the Arrays R&D budget, ensuring proper allocation and utilization of resources
Monitor and control Arrays R&D project expenses, identify cost-saving opportunities and provide recommendations for budget optimization
Collaborate with cross-functional teams to forecast resource needs including personnel, equipment, and external vendors or partners, to support project demands
Implement resource planning strategies to ensure optimal utilization of available resources while maintaining flexibility for changing project priorities
Foster strong relationships and effective collaboration with cross-functional teams, including R&D, Finance, Manufacturing, Supply Chain, Quality, and Regulatory Affairs
Lead and participate in cross-functional meetings, project reviews, and operational planning discussions to drive alignment and decision-making
Lead, mentor, and develop a high-performing team of R&D professionals, fostering a culture of excellence, collaboration, and accountability
Identify skill gaps and training needs within the team and develop appropriate learning and development programs to enhance capabilities
Conduct performance evaluations, set goals, provide feedback, and recognize achievements to drive employee engagement and professional growth
Qualification
Required
Typically requires a Bachelor's degree and a minimum of 18 years of related experience, with 10+ years of Management experience
Extensive experience with microarray technology, ideally ILMN arrays
Bachelor's or master's degree in an engineering or science discipline. PhD is a plus
Exceptional critical thinking ability
Advanced skills and experience in Program and Project Management
Proven experience in a leadership role overseeing various R&D teams
Strong understanding of R&D processes, project management methodologies, and sustaining activities
Demonstrated experience in budgeting, resource management, and financial analysis
Excellent communication and interpersonal skills, with the ability to collaborate effectively with stakeholders at all levels
Strong analytical and problem-solving abilities, with a data-driven mindset
Demonstrated leadership skills, with the ability to motivate and develop high-performing teams
Experience working in a regulated industry (e.g., healthcare, pharmaceuticals, technology) is desirable
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Recent News
2026-01-09
2026-01-07
Company data provided by crunchbase